| Financial Year |
March 31 2023 |
| Monetary Funds |
1,291,472,692.19 |
| Held-for-trading Financial Assets |
437,980,003.46 |
| Notes Receivable |
86,852,467.56 |
| Accounts Receivable |
1,139,513,002.66 |
| Advances to Suppliers |
52,013,542.96 |
| Other Receivables |
115,396,553.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
9,926,545.00 |
| Inventories |
858,952,086.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,274,577.36 |
| Total Current Assets |
4,047,524,744.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
198,647,259.22 |
| Long-term Equity Investment |
573,841,332.19 |
| Investment Properties |
26,573,792.47 |
| Fixed Assetes |
655,569,549.16 |
| Under-construction Projects |
6,958,901.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,573,365.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
394,179,790.30 |
| Deferred Income Tax Assets |
109,043,467.23 |
| Other Non-Current Assets |
26,358,805.01 |
| Sub-Total of Non-Current Assets |
2,079,324,135.52 |
| Total Assets |
6,126,848,880.35 |
| Short-Term Loans |
2,158,530,598.90 |
| Trading Financial liabilities |
98,500.00 |
| Notes Payable |
912,549,286.36 |
| Accounts Payable |
412,329,178.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,702,653.60 |
| Taxes Payable |
18,426,824.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,635,473.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,449,819.69 |
| Other Current Liabilities |
2,077,622.48 |
| Sub-Total of Current Liabilities |
3,624,781,668.40 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,630,662.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
135,073,394.10 |
| Total Liabilities |
3,759,855,062.50 |
| Paid-In Capital(Or Share Stock) |
1,229,994,500.00 |
| Capital Surplus |
1,167,334,547.66 |
| Surplus Reserve |
193,508,394.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-221,807,904.95 |
| Minority Stockholder's Interest |
20,761,142.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,346,232,675.37 |
| Owner's Equity（Stockholder's Equity） |
2,366,993,817.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,126,848,880.35 |
